Board of Directors

Douglas W. Jamison

Chairman of the Board, Chief Executive Officer & Managing Director

Mr. Jamison has served as Chairman and Chief Executive Officer since January 2009; as President and Chief Operating Officer from January 2005 to December 2008; as Treasurer from March 2005 to May 2008; as a Managing Director since January 2004; as Chief Financial Officer from January 2005 to December 2007; and as Vice President from September 2002 to December 2004. He has been a member of our Board of Directors since May 2007. Since January 2009, he has served as Chairman and Chief Executive Officer of Harris & Harris Enterprises, Inc., a wholly owned subsidiary of the Company, since 2005, he has served as a Director; and from January 2005 to December 2008 he served as President . From 1998 to 2002, Mr. Jamison worked as a Senior Technology Manager at the University of Utah Technology Transfer Office, where he managed intellectual property for the University of Utah. This included assessing technologies in both the biological sciences and the physical sciences, working with patent attorneys to develop patent protection, and developing and marketing these technologies with industry. He is a Co-Editor-in-Chief, Journal of Nanotechnology Law & Business and Co-Chair of the Advisory Board, Converging Technology Bar Association and a member of the University of Pennsylvania Nano-Bio Interface Ethics Advisory Board. He was graduated from Dartmouth College (B.A.) and the University of Utah (M.S.).

Portfolio responsibilities: Ancora Pharmaceuticals, Mersana Therapeutics, Metabolon, Nextreme Thermal Solutions and Solazyme.

Chair of the Executive Committee

W. DILLAWAY AYRES, JR.

Director since 2006

Mr. Ayres is Chief Operating Officer of Cold Spring Harbor Laboratory, a research and educational institution in the biological sciences since November 2000. Prior to joining Cold Spring Harbor Laboratory in 1998, Mr. Ayres had a 20-year business career during which he worked as a corporate executive, investment banker and entrepreneur. In 1996, he co-founded Business & Trade Network, Inc., a business-to-business, venture capital-backed internet company. Prior to that he worked for five years as a Managing Director of Veronis, Suhler & Associates, a boutique investment banking firm in New York specializing in the media/communications industry. At Veronis, Suhler, he focused on investing the firms's private equity fund. He was graduated from Princeton University (A.B.) and from Columbia University Graduate Shcool of Business (M.B.A. in Finance)

Member of the Audit Committee
Chair of the Compensation Committee
Member of the Executive Committee
Member of the Valuation Committee

PHILLIP A. BAUMAN, M.D.

Director since 1998

Dr. Bauman is a practicing orthopedic surgeon. Since 1999, he has been Senior Attending in Orthopedic Surgery at St. Luke's/Roosevelt Hospital Center in Manhattan and since 2000 has served as an elected member of the Executive Committee of the Medical Board. Since 2005, he has been on the Board of Managers for the Hudson Crossing Surgery Center. Since 1997, he has been Assistant Professor of Orthopedic Surgery at Columbia University and since 1994, a Vice President of Orthopedic Associates of New York. In 1991, he was elected a fellow of the American Academy of Orthopaedic Surgeons. Since 2005, he has consulted for Skyline Venture Partners, a venture capital firm specializing in healthcare companies. He is an active member of the American Orthopaedic Society for Sports Medicine, the American Orthopaedic Foot and Ankle Society, the New York State Society of Orthopaedic Surgeons, the New York State Medical Society and the American Medical Association. He was graduated from Harvard College (A.B.), Harvard University (A.M., Biology) and the College of Physicians and Surgeons at Columbia University (M.D.).

Member of the Compensation Committee
Member of the Nominating Committee
Member of the Valuation Committee

LUCIO L. LANZA

Director since 2010

Mr. Lanza is the Managing Director of Lanza techVentures, an early stage venture capital and investment firm, which he founded in January 2001. Since 2008, he has been a General Partner and the Chief Technology Strategist of Radnorwood Capital, LLC, an investor in public technology companies. Previously, he was a General Partner of US Venture Partners, a venture capital firm. Throughout his career, he has held senior level and strategic positions at Cadence Design Systems, Inc., EDA Systems, Inc., Daisy Systems, Corp., Intel Corp., Olivetti Corporation and ARM Holdings plc. He was graduated from Politecnico of Milano with a doctorate in electronic engineering. The Board of Directors believes that Mr. Lanza's knowledge and experience in the venture capital industry will greatly contribute to the strategic direction of the Company.

Member of the Audit Committee
Member of the Compensation Committee
Member of the Executive Committee
Chair of the Valuation Committee

CHARLES E. RAMSEY

Director since 2002

Since 1997, Mr. Ramsey has been a consultant in the area of human resources and venture capital. He is a retired founder and principal of Ramsey/Beirne Associates, Inc., an executive search firm that specialized in recruiting top officers for high-technology companies, many of which were backed by venture capital. He is a member of the board of directors and Chairman Emeritus of Bridges to Community, a non-governmental organization dedicated to construction projects in Nicaragua. As Chairman Emeritus, he serves on the Executive, Personnel and Administration and Fund Development Committees. He was graduated from Wittenberg University (B.A.).

Member of the Compensation Committee
Member of the Executive Committee
Chair of the Nominating Committee
Member of the Valuation Committee

JAMES E. ROBERTS

Director since 1995; Lead Independent Director since 2011

Mr. Roberts has been the Lead Independent Director since May 5, 2011. Since October 2009, Mr. Roberts has been Managing Vice President Corporate Underwriting with Tower Group, Inc. From January 2006 to October 2009 he was President of AequiCap Insurance Company and from September 2007, President of AequiCap Program Administrators. He was also a senior officer of various other AequipCap affiliated entities. From 2002 to 2005, he was Executive Vice President and Chief Underwriting Officer of the Reinsurance Division of Alea North America Company and Senior Vice President of Alea North American Insurance Company. From 1999 to 2002, he was Chairman and Chief Executive Officer of The Insurance Company of New York, Dakota Specialty Insurance Company, and ReCor Insurance Company Inc., all members of Trenwick Group, Ltd. Mr. Roberts has held senior executive positions with other companies in the Trenwick Group. Mr. Roberts was graduated from Cornell University (A.B.).

Member of the Compensation Committee
Member of the Executive Committee
Member of the Valuation Committee

RICHARD P. SHANLEY

Director since 2007

From 2001 to 2006, Mr. Shanley was a Partner (now retired) of Deloitte & Touche LLP. From 1976 to 2001, he worked for Eisner LLP and was a partner from 1982 until 2001. During his over 30 years of public accounting experience, he served as lead audit partner on numerous audit engagements for public and private companies and companies making public stock offerings, including those requiring application of Sarbanes-Oxley Section 404. He served as lead audit partner primarily for biotech, pharmaceutical and high-tech companies, including companies enabled by nanotechnology. He has been actively involved on the Biotech Council of New Jersey, the New Jersey Technology Council, the New York Biotechnology Association, the Connecticut Venture Group, the Biotechnology Industry Organization and the NanoBusiness Alliance. He is a member of the board of directors of Redpoint Bio Corporation, a publicly held biotechnology company. He is an active member of the New York State Society of Certified Public Accountants and the American Institute of Certified Public Accountants. He is currently serving his fifth term on the New York State Society of CPA's Professional Ethics Committee and as of June 2009 is chairing that committee. He is a licensed Certified Public Accountant in New York. He was graduated from Fordham University (B.S.) and Long Island University (M.B.A. in Accounting).

Chair of the Audit Committee
Member of the Executive Committee
Member of the Nominating Committee
Member of the Valuation Committee

BRUCE W. SHEWMAKER

Director since 2011

Since November 2003, Mr. Shewmaker has been a Managing Director of MVC Capital, Inc., a publicly traded business development company listed on the NYSE ("MVC"). Previously, he was a Managing Director of E*Offering Corp., an investment banking firm that was later merged into WIT Sound View Group, from 1999 to 2001. From 1997 to 1998, Mr. Shewmaker served as President and Director of The US Russia Investment Fund, where he managed a staff of approximately 60 people in seven offices across the Russian Federation. Throughout his career, he has held senior level and strategic positions at New Century Management, Vector Venture Partners Group, Merrill Lynch R&D Management, Inc., Merrill Lynch Oklahoma Venture Partners, L.P. and Merrill Lynch Venture Capital, Inc. He is a Director of several privately held companies: Foliofn, Inc., Velocitius B.V., and Vestal Manufacturing Enterprises, Inc. Earlier this year, Mr. Shewmaker agreed to serve as an independent director of Garrison Capital Inc., a newly organized business development company currently in registration for its initial public offering. He was graduated from The Ohio State University (B.S.) and has completed graduate work in Management Studies at New York University's Leonard N. Stern School of Business.

Member of the Audit Committee
Member of the Nominating Committee
Member of the Valuation Committee